soul study semaglutide Updates in Medicine | 🩺 Oral Cuts CV Risk in High-Risk T2DM – Trial (NEJM, Mar 2025) 🔗 Original article link in bio 📌 Key Highlights: 🔹 soul study semaglutide Oral and

Stay Hydrated Drink plenty of water before, during, and after consuming alcohol to reduce the risk of dehydration

Patients should be advised to: Start with the lowest dose and increase slowly Eat smaller, more frequent meals Avoid high-fat foods Stay well-hydrated Safety monitoring should include vigilance for: Pancreatitis symptoms (severe persistent abdominal pain) discontinue immediately if suspected Gallbladder disease increased risk with rapid weight loss Hypoglycaemia particularly when combined with insulin or sulphonylureas Renal function deterioration especially with dehydration from gastrointestinal effects Diabetic retinopathy monitor in patients with pre-existing retinopathy, particularly with semaglutide Suspected adverse reactions should be reported via the MHRA Yellow Card scheme

Semaglutiidi kummikommid , kui uuenduslik ravimi annustamisvorm, kombineerib seda kummikommide vormiga, et parandada patsientide ravisoostumust

[PMID: 7256186] PubMed record related to this compound for laboratory literature review